Michelle Mathy
Partner /
Michelle Mathy is a partner at Capitol Counsel, LLC. She brings an extensive background in healthcare provider and biopharmaceutical knowledge to the firm, having cultivated nearly two decades of experience in government relations at healthcare organizations and companies. As Head of Federal Affairs at Otsuka American Pharmaceuticals Inc., Mathy led efforts to advance policies improving mental health care access, treatment availability, and digital health technology. Before this, she held roles at the American Hospital Association, the American Society of Anesthesiologists, and the American Academy of Dermatologists, where she oversaw multi-million-dollar political action committees. She also served as the Director of Government Affairs and Policy at Biogen, Inc., where she was a business unit leadership team member collaborating with executives across Market Access, Value and Access, Medical Affairs, Clinical Affairs, and Sales on product launches.
Education
- Southern Illinois University Carbondale – B.A. & B.S.
Positions Held
- Otsuka Pharmaceutical Companies – Head of Federal Affairs
- Biogen Inc. – Director, Public Policy & Governmental Affairs
- American Academy Of Dermatology Association – Associate Director, Congressional & Political Affairs
- America Society of Anesthesiologists – Senior Political Affairs Manager and Congressional Lobbyist
- AHAPAC and Grassroots Advocacy – Specialist
Memberships / Recognition
- National Minority Quality Forum – Advisory Board Member
- Digital Health for Equitable Health Coalition – Founding Board Member (former)
Successes
As Head of Federal Affairs at Otsuka American Pharmaceuticals Inc., Mathy was responsible for developing and executing Otsuka’s strategy to advance policies that improve patient access to mental health care, increase patient access to treatments, and advance digital health technology. She and her team engaged with members of Congress, administration officials, trade associations, diplomats, patient organizations, coalitions, and political organizations. Mathy was ultimately successful in securing an on-ramp for companies serving low-income subsidy patients in Medicare’s Part D redesign under the Inflation Reduction Act.
At the AADA, Mathy successfully influenced legislative and regulatory proposals affecting dermatology, including Medicare parts B, C, and D.
Additionally, Mathy has successfully run a $4 million PAC for the American Society of Anesthesiologists.